Ashish Kumar

The present research work was aimed to enhance the solubility and dissolution rate of Olanzapine using Poloxamer as carrier by preparing solid dispersion. The solid dispersions and physical mixtures prepared was also evaluated  for the drug content and percentage drug yield and characterization of prepared systems is done with the help of in-vitro drug release, FTIR, XRD and DSC analysis. The results obtained showed that the percentage yield and percentage drug content was 98.32% and 99% respectively. It was clear that there was no loss of drug and polymer. The rate of dissolution of the drug in the case of solid dispersions was much enhanced as compared to the pure drug and their physical mixtures. FTIR spectra showed that there was not any interaction or hydrogen bonding between the drug and polymers in solid dispersions as well as physical mixtures. The polymorphic changes were studied with the XRD gave the idea that the solid dispersions were quite amorphous in nature as compared to the pure drug. In the diffraction pattern for solid dispersions, the number of crystalline peaks due to drug had disappeared. DSC showed that there was shifting in melting endotherm of drug in case of solid dispersion. From the XRD and DSC it was confirmed that the increase in the solubility and dissolution rate was due to polymorphic transition of drug from crystalline to amorphous form.

The objective of this research work was to formulate and evaluate the floating drug delivery system containing Pantoprazole sodium sesquihydrate as a model drug and to optimize its drug release profile. Pantoprazole sodium tablets were prepared by direct compression technique. Formulations contained Xanthan gum, PVP K30 and gas generating agent such as sodium bicarbonate and citric acid were taken as independent variables. The physical parameters of the tablets were characterized and were found within the limits. By comparing dissolution profiles of different formulations, the formulation F5 was considered as a better formulation. The drug release from all the formulations was found to follow zero order kinetics and Peppas modeling. The diffusion exponent of formulations was found (n

The aim of present study,  To formulate and characterized  proniosome contain flurbiprofen in a gel formulation for the treatment of rheumatoid arthritis and enhanced skin targeted effect, sustained & prolonged drug release, enhanced skin bioavailability by using different type of non ionic surfactant & cholesterol. The batches were designed using Box Behnken Design and prepared by coacervation phase separation method. Optimized formulation (PNGopt) showed drug entrapment efficiency of 74.46% and particle size 215nm. In-vitro drug release from PNGopt was found to be 84.15 in 24 hrs. The In-vitro drug release was best explained by zero order kinetics as the plot showed highest linearity and release was governed by Quasi Fickian diffusion.

The aim of this study was to prepare Diclofenac potassium (DP) microspheres by using Double Emulsion-solvent evaporation method with ethyl cellulose (EC) and Eudragit polymers. An attempt was made to formulate a sustained release dosage form of diclofenac potassium, to minimize frequent dosing as well as reducing or eliminating local side effects by avoiding the drug release in the upper gastro-intestinal tract Poly vinyl alcohol containing 2% (w/w) span 80 was the external phase and polymer -drug solution was the internal phase. EC and Eudragit were used to encapsulate diclofenac potassium. By using different formulation variables, six different formulations (F1, F2, F3, F4, F5, & F6) were prepared. The resulting microspheres obtained, were more spherical in shape and showed more entrapment efficiency. The size of the microspheres varied between 346-695 μm and as high as 96.24% loading efficiency for Eudragit and 82.34% for EC was obtained. In vitro release study was carried out in 0.1 N hydrochloric acid solution (pH 1.2) for first 2 hours followed by in phosphate buffer solution (pH 6.8) for next 4 hours. After first 2 hours of dissolution in 0.1 N hydrochloric acid, EC microspheres released 23% of drug and Eudragit released 7% of drug. The formulations were found to be effective in providing controlled release of drug for a longer period of time.

The proniosomal approach helps to solve the problem regarding stability and provides higher entrapment efficiency over conventional system. Proniosomal gel is a liquid crystalline- compact niosomal hybrid which is prepared by dissolving surfactant in small amount of suitable solvent and least amount of aqueous phase. This compact gel can be converted to niosomes hydration. Proniosomes can entrap hydrophilic as well as lipophillic drugs. Proniosomal gel offers a versatile vesicle drug delivery concept with potential for drug delivery via transdermal rout. Over the last few years an inclusive research has been done over pro-vesicular approach for transdermal drug delivery. Skin has a very tough diffusion barrier inhibiting penetration of drug moiety which is rate limiting barrier for penetration of drugs. There are several approaches that deal with penetration enhancement across the skin. Vesicular and provesicular systems are promising amongst them. Vesicular systems including (niosomes, ethosomes, transfersomes and liposomes) are promising systems to cross this permeation barrier.

Over the last few years an inclusive research has been done over provesicular approach for transdermal drug delivery. Skin has a very tough diffusion barrier inhibiting penetration of drug moiety which is rate limiting barrier for penetration of drugs. There are several approaches that deal with penetration enhancement across the skin. Vesicular and provesicular systems are promising amongst them. Vesicular systems including (niosomes, ethosomes, transfersomes and liposomes) are promising systems to cross this permeation barrier. The proniosomal approach helps to solve the problem regarding stability and provides higher entrapment efficiency over conventional system. Proniosomal gel is a liquid crystalline- compact niosomal hybrid which is prepared by dissolving surfactant in small amount of suitable solvent and least amount of aqueous phase. This compact gel can be converted to niosomes hydration. Proniosomes can entrap hydrophilic as well as lipophillic drugs. Proniosomal gel offers a versatile vesicle drug delivery concept with potential for drug delivery via transdermal rout.

The present study aims at the formulation of a floating drug delivery system of an antiulcer drug nizatidine using different grades of HPMC (K100, K4M, K15M & K100M) and an effervescent agent i.e. sodium bicarbonate. It was found that the release rate of nizatidine from tablet formulations prepared from HPMC K100LV was very high as compared to that from formulations containing higher viscosity grades namely K4M, K15M and K100M. In the current study, it was also found that overall rate of drug release tends to decrease with increase in concentration of HPMC. These observations are in agreement with the results reported in literature i.e. with the increase in polymer concentration and viscosity grade, the viscosity of gel layer around the tablet also increases leading to enhanced diffusional path length for the drug to follow and thus limits the release of active ingredient.